Harvard University researchers have found the diabetes drug Avandia can be harmful to heart and can lead to death. The study was led by Dr. Wolfgang Winkelmayer of Brigham and Women’s Hospital in Boston. He and his colleagues reported people aged 65 and older who took Avandia (rosiglitazone) had a 15 percent higher rate of death after an average of one year.
Diabetic retinopathy is a very common but serious eye related complication. Though it can effect any diabetic patient easily, but almost all person with type 1 diabetes show some symptoms of diabetic retinopathy usually after about 20 years of living with diabetes.